Evaluating the Cardiovascular Impact of Genetically Proxied PCSK9 and HMGCR Inhibition in East Asian and European Populations: A Drug-Target Mendelian Randomization Study.

Rosoff DB., Bell AS., Mavromatis LA., Hamandi A., Park L., Jung J., Wagner J., Pacher P., Ray D., Davey Smith G., Lohoff FW.

DOI

10.1161/CIRCGEN.122.004224

Type

Journal article

Journal

Circ Genom Precis Med

Publication Date

23/01/2024

Keywords

Mendelian randomization analysis, atrial fibrillation, cardiovascular diseases, coronary artery disease, humans

Permalink Original publication